ELAB vs BDRX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 14, 2026

ELAB

50.1
AI Score
VS
ELAB Wins

BDRX

38.5
AI Score

Investment Advisor Scores

ELAB

50score
Recommendation
HOLD

BDRX

39score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric ELAB BDRX Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -45.8% -64.1% ELAB
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 50.1/100 38.5/100 ELAB
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY ELAB

Relative Price Performance (Last 90 Days)

ELAB 1M: -40.1% · 3M: +194.1% BDRX 1M: -37.5% · 3M: -73.1%

Current Technical Phase

ELAB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 33

RSI (14): 33.3 · Price: $2.71

BDRX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -35.8%), weak momentum, RSI 37

RSI (14): 37.0 · Price: $0.42

Fundamentals Snapshot

Metric ELAB BDRX
Market Cap — —
Forward P/E 0.0 0.0
Trailing P/E — 0.0
Revenue (TTM) — —
Revenue Growth -0.5% -0.6%
Gross Margin -0.2% -62.8%
Operating Margin -2.9% 0.0%
EPS -1672.89 62.90
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ELAB is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.